Dendritic cells in cancer vaccines

By Brossart P.   Wirths S.   Brugger W.   Kanz L.  

Experimental Hematology, Vol. 29, Iss. 11, 2001-11 ,pp. : 1247-1255

Elsevier

Access to resources Recommend Favorite

Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells

By Imai Jun   Hasegawa Hironori   Maruya Mikako   Koyasu Shigeo   Yahara Ichiro  

International Immunology, Vol. 17, Iss. 1, 2005-01 ,pp. : 45-53

Oxford University Press

Access to resources Recommend Favorite

Monitoring indirect presentation of alloantigens by utilizing the autologous processing machinery of dendritic cells in-vitro

By Tambur A.R.  

Journal of Immunological Methods, Vol. 283, Iss. 1, 2003-12 ,pp. : 215-223

Elsevier

Access to resources Recommend Favorite

Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming

By Zehn Dietmar   Cohen Cyril J.   Reiter Yoram   Walden Peter  

International Immunology, Vol. 18, Iss. 12, 2006-12 ,pp. : 1647-1654

Oxford University Press

Access to resources Recommend Favorite

Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies

By Kalinski Pawel   Muthuswamy Ravikumar   Urban Julie  

Expert Review of Vaccines, Vol. 12, Iss. 3, 2013-03 ,pp. : 285-295

Informa Healthcare

Access to resources Recommend Favorite